• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肌肉6-磷酸果糖激酶cDNA的分离

Isolation of a cDNA for human muscle 6-phosphofructokinase.

作者信息

Vora S, Hong F, Olender E

出版信息

Biochem Biophys Res Commun. 1986 Mar 13;135(2):615-21. doi: 10.1016/0006-291x(86)90037-9.

DOI:10.1016/0006-291x(86)90037-9
PMID:2938579
Abstract

A cDNA for human muscle 6-phosphofructokinase (EC.2.7.1.11) has been isolated from a human fibroblast cDNA library made using the Okayama-Berg procedure. The cDNA isolated as a Bam H1 fragment of the pcD recombinant, pO4, is approximately 2000 bp in length. It represents approximately 1350 bp of the C-terminus coding sequence of the enzyme, approximately 500 bp of the 3'-untranslated region and approximately 150 bp of the vector sequences. The identity of the pO4 cDNA was established by the observation of a high degree of homology (approximately 95%) between the deduced amino acid sequence with the published protein sequence of rabbit muscle 6-phosphofructokinase, and the assignment of the sequence to human chromosome 1 (the known location of PFKM) by using somatic cell hybrids. Based on immunochemical evidence, we had previously predicted not only a remarkable structural conservation of the vertebrate muscle PFK, but also partial structural identity among all three vertebrate PFK isozymes. The pO4 cDNA is, therefore, expected to permit isolation of cDNAs for muscle and non-muscle PFKs from a wide variety of vertebrate species.

摘要

已从一个使用冈本-伯格方法构建的人成纤维细胞cDNA文库中分离出编码人肌肉6-磷酸果糖激酶(EC.2.7.1.11)的cDNA。作为pcD重组体pO4的Bam H1片段分离出的cDNA长度约为2000 bp。它代表该酶C端编码序列约1350 bp、3'-非翻译区约500 bp以及载体序列约150 bp。通过观察推导的氨基酸序列与已发表的兔肌肉6-磷酸果糖激酶蛋白质序列之间的高度同源性(约95%),以及利用体细胞杂种将该序列定位到人染色体1(PFKM的已知位置),确定了pO4 cDNA的身份。基于免疫化学证据,我们之前不仅预测了脊椎动物肌肉磷酸果糖激酶在结构上有显著保守性,而且预测了所有三种脊椎动物磷酸果糖激酶同工酶之间存在部分结构同一性。因此,预计pO4 cDNA能够从多种脊椎动物物种中分离出肌肉和非肌肉磷酸果糖激酶的cDNA。

相似文献

1
Isolation of a cDNA for human muscle 6-phosphofructokinase.人肌肉6-磷酸果糖激酶cDNA的分离
Biochem Biophys Res Commun. 1986 Mar 13;135(2):615-21. doi: 10.1016/0006-291x(86)90037-9.
2
Isolation and sequence of a cDNA encoding human platelet phosphofructokinase.
Biochem Biophys Res Commun. 1991 Oct 15;180(1):197-203. doi: 10.1016/s0006-291x(05)81276-8.
3
Cloning and expression of a human muscle phosphofructokinase cDNA.
Gene. 1989 Apr 15;77(1):177-83. doi: 10.1016/0378-1119(89)90372-7.
4
Sequence diversity in the 5' untranslated region of rabbit muscle phosphofructokinase mRNA.
Biochem Biophys Res Commun. 1990 Aug 16;170(3):1056-60. doi: 10.1016/0006-291x(90)90499-d.
5
The rabbit muscle phosphofructokinase gene: cDNA cloning and sequencing.兔肌肉磷酸果糖激酶基因:cDNA克隆与测序
Proc Natl Sci Counc Repub China B. 1990 Apr;14(2):69-74.
6
Cloning of human muscle phosphofructokinase cDNA.人肌肉磷酸果糖激酶cDNA的克隆
FEBS Lett. 1987 Oct 19;223(1):113-6. doi: 10.1016/0014-5793(87)80519-7.
7
Assignment of the human gene for muscle-type phosphofructokinase (PFKM) to chromosome 1 (region cen leads to q32) using somatic cell hybrids and monoclonal anti-M antibody.利用体细胞杂种和抗M单克隆抗体将人类肌肉型磷酸果糖激酶(PFKM)基因定位于1号染色体(cen区至q32区)。
Somatic Cell Genet. 1982 Jan;8(1):95-104. doi: 10.1007/BF01538653.
8
A cDNA encoding canine muscle-type phosphofructokinase.
Gene. 1996 Feb 12;168(2):275-6. doi: 10.1016/0378-1119(95)00761-x.
9
Mapping of the Na+, K(+)-ATPase subunit alpha 2 (ATP1A2) and muscle phosphofructokinase (PFKM) genes in pig by somatic cell hybrid analysis.通过体细胞杂交分析对猪的钠钾ATP酶α2亚基(ATP1A2)基因和肌肉磷酸果糖激酶(PFKM)基因进行定位。
Anim Genet. 1999 Feb;30(1):57-9. doi: 10.1046/j.1365-2052.1999.00407.x.
10
Cloning and characterization of a cDNA encoding phosphofructokinase from Schistosoma mansoni.曼氏血吸虫磷酸果糖激酶编码cDNA的克隆与特性分析
Mol Biochem Parasitol. 1994 Jul;66(1):105-10. doi: 10.1016/0166-6851(94)90040-x.

引用本文的文献

1
Tumor-specific lytic path "hyperploid progression mediated death": Resolving side effects through targeting retinoblastoma or p53 mutant.肿瘤特异性裂解途径“超倍体进展介导的死亡”:通过靶向视网膜母细胞瘤或p53突变体解决副作用。
World J Clin Oncol. 2020 Nov 24;11(11):854-867. doi: 10.5306/wjco.v11.i11.854.
2
Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency.患有糖原累积症VII型的阿什肯纳兹犹太患者中磷酸果糖激酶-M基因的常见突变及其群体频率。
Am J Hum Genet. 1994 Aug;55(2):305-13.
3
Novel clustering of Sp1 transcription factor binding sites at the transcription initiation site of the human muscle phosphofructokinase P1 promoter.
人类肌肉磷酸果糖激酶P1启动子转录起始位点处Sp1转录因子结合位点的新型聚类
Nucleic Acids Res. 1994 Nov 25;22(23):5085-92. doi: 10.1093/nar/22.23.5085.
4
Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.迟发性肌肉磷酸果糖激酶缺乏症中酶缺陷的特征。糖原贮积病VII型的新亚型。
J Clin Invest. 1987 Nov;80(5):1479-85. doi: 10.1172/JCI113229.